Skip to content
Find an ETF
← All ETFs

Available in 10 markets

iShares Genomics Immunology and Healthcare ETF

iShares · US46435U1925

iShares Genomics Immunology and Healthcare ETF is an exchange-traded fund (ETF) from iShares, traded under the ticker IDNA (ISIN US46435U1925). In a single purchase you get a diversified basket of holdings rather than a stake in just one business. In plain terms it is about owning small slices of companies, so you share in their growth when they do well…

Equity ?Unknown Physical ?
Mid-range feeOwns the shares directlyOther
Find funds like this

Opens the screener with this filter applied.

Fund size (AUM) ?
€0
1-year return ?
+54.1%
Price Return · to 2026-07-21
Yearly fee (TER) ?
0.47%
All-in cost ≈ 0.00%

About this fund

How it works

The fund actually buys every share in the index it tracks (full replication).

Read more

Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.

Cost

0.47%Yearly fee (TER)
0.00%All-in cost

The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.

Read more

For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.

Fund facts

Replication ?
Physical
Full — buys every share
Launched
Jun 2019
7-year track record

Performance

26.747.167.588.0108202120242026

Growth of $100 invested — the line starts at $100.

iShares Genomics Immunology and Healthcare ETF

End-of-day prices, rebased to a common start so the shapes are comparable. Past performance does not predict future results.

YTD+25.4%
1 year+54.1%
3 years+11.1%
5 years-8.1%

Return, year by year

-42.5
-8.6
-1.6
+15.7
'22'23'24'25
1 of 4 up yearsBest: 2025 +15.7%Worst: 2022 -42.5%Calendar-year total returns, in USD

How bumpy has it been?

25.2%
Volatility (1y) ?
How much the price swings year to year — lower is calmer.
-29.8%
Worst drop (3y) ?
The biggest fall from a peak over the last three years.
0.44
Return for the risk (3y) ?
Reward earned per unit of bumpiness.

The bigger picture

-32.6%
Since inception
Total growth since launch — about -7.6% a year.
+68.1%
Best 12 months
The strongest one-year stretch on record.
-52.4%
Worst 12 months
The weakest one-year stretch on record.
-68.7%
Worst fall on record ?
It has not fully recovered yet.

Where to buy this fund

Set from your language & location — change it if it's wrong.

Where it trades

ExchangeTickerCurrency
NYSEIDNAUSD★ Primary
EUR listings
Frankfurt0IJ8EUR
USD listings
B4IDNAUSDUSD
CCIDNACLUSD
CCIDNAUSD
CEIDNAUSD
CEIDNACLUSD
CIIDNAUSD
CIIDNACLUSD
E1IDNAUSDUSD
EPIDNAUSDUSD
EUIDNAUSDUSD
EZIDNAUSDUSD
GM0IJ8USD
MFIDNA*USD
MMIDNA*USD
MUIDNA*USD
NYSE ArcaIDNAUSD
OCIDNAUSD
ODIDNAUSD
UAIDNAUSD
UBIDNAUSD
UCIDNAUSD
UDIDNAUSD
UFIDNAUSD
UMIDNAUSD
USIDNAUSD
UTIDNAUSD
UXIDNAUSD
VFIDNAUSD
VGIDNAUSD
VJIDNAUSD
VKIDNAUSD
VPIDNAUSD
VYIDNAUSD
X1IDNAUSDUSD
X2IDNAUSDUSD
XAIDNAUSDUSD
XEIDNAUSDUSD
XETRAIDNAUSD
XFIDNAUSDUSD
XGIDNAUSDUSD
XHIDNAUSDUSD
XJIDNAUSDUSD
XLIDNAUSDUSD
XOIDNAUSDUSD
XQIDNAUSDUSD
XSIDNAUSDUSD
XUIDNAUSDUSD
XVIDNAUSDUSD
XWIDNAUSDUSD
XXIDNAUSDUSD
XZIDNAUSDUSD
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows

How it ranks vs peers

🪙 Cheaper than 31% of similar ETFs📈 Higher 1-yr return than 96%📈 Higher 3-yr return than 44%📈 Higher 5-yr return than 1%📊 Beat its category by 36.4% (1-yr) (category average +17.8%)📊 Behind its category by 0.4% (3-yr) (category average +11.5%)📊 Behind its category by 13.4% (5-yr) (category average +5.3%)

Versus the Equity (stocks) · Other · USD ETFs we track.

Advanced risk

0.65
Sortino (3y) ?
0.37
Calmar (3y) ?
15.6%
Downside deviation ?
75%
Up months (hit rate) ?
$34.91
52-week high ?
$21.06
52-week low ?

Similar funds

We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.

Matched on🌍 Other stocks
Compare side by side
6 similar funds
iShares Genomics Immunology and Healthcare ETFiSharesYou're viewingState Street® Technology Select Sector SPDR® ETFSPDRBroader matchSchwab International Equity ETFSchwabBroader matchInvesco S&P 500 UCITS ETF AccInvescoBroader matchState Street® Financial Select Sector SPDR® ETFSPDRBroader matchState Street® SPDR® S&P® 500 MXN Hdg UCITS ETF (Acc)SPDRBroader matchState Street® SPDR® S&P® 500 GBP Hdg UCITS ETF (Dist)SPDRBroader match
Why it's similarThis is the fund on this page.
StocksUnknownPhysicalCheaper fee
StocksUnknownPhysicalCheaper fee
StocksCheaper fee
Copies the index with a swap, not by holding the shares.
StocksUnknownPhysicalCheaper fee
StocksPhysicalCheaper fee
StocksPhysicalCheaper fee
Index trackedTechnology Select Sector IndexFTSE Developed ex US IndexS&P 500® Total Return (Net) IndexFinancial Select Sector Index® ® S&p® 500 Mxn Hdg® ® S&p® 500 Hdg
Yearly fee (TER)0.47%0.08%0.03%0.05%0.08%0.05%0.05%
All-in cost0.00%0.00%0.00%0.12%0.00%0.06%0.06%
Fund size€0€100.7B€57.6B€50.3B€48.9B€36.7B€36.7B
DomicileUnited StatesUnited StatesIrelandUnited StatesIrelandIreland
ReplicationPhysical (full)Physical (full)Physical (full)Synthetic (swap)Physical (full)Physical (full)Physical (full)
3-yr return p.a.+11.1%+26.5%+13.9%-73.9%+16.7%
5-yr return p.a.-8.1%+18.6%+6.7%+9.2%
# holdings771,49457280505505

The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.

Open the full comparison tool →
Data as of 2026-07-21 · Source: issuer data, compiled by Finance Hamster

New to ETFs? Start with the basics →

Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.